Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/scd.2020.0071 http://scihub22266oqcxt.onion/10.1089/scd.2020.0071 32292113!7247051!32292113     free     free     free       Stem+Cells+Dev 2020 ; 29 (11): 679-681 Nephropedia Template TP {{tp|p=32292113|t=2020. Stem Cell-Based Therapy for Coronavirus Disease 2019 |pdf=|usr=}}{{32292113}} gab.com Text Stem Cell-Based Therapy for Coronavirus Disease 2019 JO: Stem Cells Dev http://www.kidney.de/pget.php?&tw=1&pmid=32292113 #FOAvip The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation. Twit Text FOAVip Stem Cell-Based Therapy for Coronavirus Disease 2019 ????Stem Cells Dev http://www.kidney.de/pget.php?&tw=1&pmid=32292113 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32292113 #FOAvip English Wikipedia <ref>{{Cite pmid|32292113}}</ref> Stem Cell-Based Therapy for Coronavirus Disease 2019 #MMPMID32292113 Zhao RC Stem Cells Dev 2020[Jun]; 29 (11): 679-681 PMID32292113show ga The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation. |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Cell Differentiation/physiology[MESH] |Cell- and Tissue-Based Therapy/*methods[MESH] |Coronavirus Infections/*therapy[MESH] |Dendritic Cells/cytology/*immunology[MESH] |Humans[MESH] |Mesenchymal Stem Cell Transplantation/*methods[MESH] |Mesenchymal Stem Cells/cytology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*therapy[MESH]Stem Cell-Based Therapy for Coronavirus Disease 2019 (epmc).pdf DeepDyve Pubget Overpricing